Analytics

Patients are showing an increasing appreciation for remote diagnostic eye care, says Notal Vision CEO Kester Nahen.

The Alessi Agenda: Data-driven decision-making improves outcomes in the public health setting, as supported by cancer registries being shifted onto a digital platform, explains Duncan Selbie, former chief executive at Public Health England.

Governments must effectively leverage behavioral, economic and movement data to improve outcomes during future pandemics, says Dame Sally Davies, former CMO for England and current Master of Trinity College in Cambridge, UK.

The pandemic has encouraged stakeholders to collaborate more effectively on the use of data, which HIPPO AI Foundation founder Bart De Witte hopes will help reduce health inequalities in a post-coronavirus world.

Imagia is expanding artificial intelligence into cancer research, says Florent Chandelier, CTO of the Montreal-based software startup.

Clinicians can leverage evidence-based knowledge in a meaningful way that can help at the bedside during situations such as COVID-19, says Dr. Ian Chuang, chief medical officer for Elsevier's EMEALAAP Health business.

Thryve founder and CEO Friedrich Lämmel says extracting high-quality data can help improve patient outcomes by providing personalized treatments more efficiently via digital solutions.

To ensure effective adoption, health data systems must be based on infrastructure and mechanisms that people can trust, says Dr. Ceri Thompson, deputy head of the eHealth, Wellbeing and Ageing unit at the European Commission.

The NHS AI Lab will help facilitate the adoption of artificial intelligence into clinical settings, but quality of data is imperative, says Indra Joshi, director of AI at the NHSX.

Israel's military defense expertise fueled the production of medical devices, diagnostics and other data intelligence tools in response to COVID-19, says Brig. Gen. (Ret.) Dr. Daniel Gold.